Detection of TSH receptor RNA in cultured fibroblasts from patients with Graves' ophthalmopathy and pretibial dermopathy
- PMID: 7509671
- DOI: 10.1089/thy.1993.3.297
Detection of TSH receptor RNA in cultured fibroblasts from patients with Graves' ophthalmopathy and pretibial dermopathy
Abstract
Fibroblasts are target cells for the autoimmune process in Graves' ophthalmopathy and pretibial dermopathy. Because the autoantigen involved in the hyperthyroidism of Graves' disease is the TSH receptor, we sought to determine whether RNA encoding this receptor might be present in retroocular and pretibial fibroblasts. RNA was reverse transcribed and the resulting cDNA was amplified by the polymerase chain reaction using primers spanning a region of the extracellular domain of the human TSH receptor. The predicted amplified product, verified by direct sequencing, was detected when RNA was derived from fibroblasts, but not from the nonfibroblast cells studied. The demonstration in fibroblasts of RNA encoding this important autoantigen in Graves' disease suggests that the TSH receptor might play a role in the pathogenesis of the connective tissue manifestations of this disease.
Similar articles
-
A genomic point mutation in the extracellular domain of the thyrotropin receptor in patients with Graves' ophthalmopathy.J Clin Endocrinol Metab. 1994 Feb;78(2):256-60. doi: 10.1210/jcem.78.2.7508946. J Clin Endocrinol Metab. 1994. PMID: 7508946
-
TSH receptor transcripts and TSH receptor-like immunoreactivity in orbital and pretibial fibroblasts of patients with Graves' ophthalmopathy and pretibial myxedema.Thyroid. 1997 Feb;7(1):3-12. doi: 10.1089/thy.1997.7.3. Thyroid. 1997. PMID: 9086563
-
TSH and TSH receptor antibody-binding sites in fibroblasts of pretibial myxedema are related to the extracellular domain of entire TSH receptor.Clin Immunol Immunopathol. 1994 Apr;71(1):113-20. doi: 10.1006/clin.1994.1059. Clin Immunol Immunopathol. 1994. PMID: 8137554
-
Retroocular fibroblasts: important effector cells in Graves' ophthalmopathy.Thyroid. 1992 Spring;2(1):89-94. doi: 10.1089/thy.1992.2.89. Thyroid. 1992. PMID: 1525575 Review.
-
Role of connective tissue autoimmunity in Graves' ophthalmopathy.Autoimmunity. 1992;13(1):75-9. doi: 10.3109/08916939209014638. Autoimmunity. 1992. PMID: 1420809 Review.
Cited by
-
Pathogenesis of graves ophthalmopathy: implications for prediction, prevention, and treatment.Am J Ophthalmol. 2006 Jul;142(1):147-153. doi: 10.1016/j.ajo.2006.02.047. Am J Ophthalmol. 2006. PMID: 16815265 Free PMC article. Review.
-
Establishment of a tear protein biomarker panel differentiating between Graves' disease with or without orbitopathy.PLoS One. 2017 Apr 18;12(4):e0175274. doi: 10.1371/journal.pone.0175274. eCollection 2017. PLoS One. 2017. PMID: 28419103 Free PMC article.
-
The evaluation of retrobulbar fat tissue in Graves' orbitopathy with shear-wave ultrasound elastography.Int Ophthalmol. 2024 Feb 6;44(1):13. doi: 10.1007/s10792-024-02962-9. Int Ophthalmol. 2024. PMID: 38321200
-
Gene expression profiling of orbital adipose tissue from patients with Graves' ophthalmopathy: a potential role for secreted frizzled-related protein-1 in orbital adipogenesis.J Clin Endocrinol Metab. 2005 Aug;90(8):4730-5. doi: 10.1210/jc.2004-2239. Epub 2005 May 10. J Clin Endocrinol Metab. 2005. PMID: 15886250 Free PMC article.
-
Teprotumumab as a Novel Therapy for Thyroid-Associated Ophthalmopathy.Front Endocrinol (Lausanne). 2020 Dec 17;11:610337. doi: 10.3389/fendo.2020.610337. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 33391187 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical